Gene expression profiling of CD8+ T cells predicts prognosis in patients with Crohn disease and ulcerative colitis-Reference-Cited by-同舟云学术

Gene expression profiling of CD8+ T cells predicts prognosis in patients with Crohn disease and ulcerative colitis

Published:2011-10-03 Issue:10 Volume:121 Page:4170-4179
ISSN:0021-9738
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:J. Clin. Invest.

Author:

Lee James C.,Lyons Paul A.,McKinney Eoin F.,Sowerby John M.,Carr Edward J.,Bredin Francesca,Rickman Hannah M.,Ratlamwala Huzefa,Hatton Alexander,Rayner Tim F.,Parkes Miles,Smith Kenneth G.C.

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Reference56 articles.

1. Recent trends in the epidemiology of inflammatory bowel diseases: Up or down

2. Changes in Clinical Characteristics, Course, and Prognosis of Inflammatory Bowel Disease during the Last 5 Decades: A Population-Based Study from Copenhagen, Denmark

3. Clinical Course in Crohn’s Disease: Results of a Norwegian Population-Based Ten-Year Follow-Up Study

4. Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial

5. Top-down therapy for IBD: rationale and requisite evidence

Cited by 276 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biobanks and biomarkers: Their current and future role in biomedical research;World Journal of Methodology;2024-12-20

2. Epithelial barrier dysfunction and microbial dysbiosis: exploring the pathogenesis and therapeutic strategies for Crohn’s disease;Tissue Barriers;2024-08-26

3. Lymphocyte subsets for predicting inflammatory bowel disease progression and treatment response: a systematic review;Frontiers in Immunology;2024-08-20

4. Nordic inflammatory bowel disease treatment strategy trial: protocol for the NORDTREAT randomised controlled biomarker-strategy trial;BMJ Open;2024-07

5. Treatment strategies and biomarkers in Crohn's disease: the PROFILE trial;The Lancet Gastroenterology & Hepatology;2024-07